Literature DB >> 18639866

Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study.

Bogdan Galusca1, Nicolas Costes, Natacha Germain Zito, Roland Peyron, Cecile Bossu, Francois Lang, Didier Le Bars, Bruno Estour.   

Abstract

BACKGROUND: Serotonin (5-HT) pathway abnormalities were demonstrated in anorexia nervosa (AN). Brain imaging studies on 5-HT receptors support this evidence. 4-(2-methoxyphenyl)-1-[2-(N-2-pyridinyl)-p-fluorobenzamido]-ethylpiperazine ([(18)F]MPPF) is a selective 5-HT(1A) receptor antagonist with an affinity close to that of endogenous 5-HT.
METHODS: In 24 subjects including 8 lean restrictive-type AN patients, 9 recovered from restrictive-type AN subjects and 7 age-matched control subjects, we assessed in vivo brain [(18)F]MPPF binding by positron emission tomography and eating-related psychopathological traits. Inter-groups differences in [(18)F]MPPF binding were evaluated by voxel-based analyses.
RESULTS: Restrictive AN patients presented increased [(18)F]MPPF binding in a selective area of the right cortex including part of the superior temporal gyrus, inferior frontal gyrus, parietal operculum, and temporoparietal junction. Striking regional similarities of increased [(18)F]MPPF binding were found in recovered from AN subjects. Most of the psychiatric scores were increased in restrictive AN patients, and elevated perfectionism and interpersonal distrust scores were noticed in subjects recovered from AN.
CONCLUSIONS: The persistent increased 5-HT(1A) receptor binding in frontotemporal region of recovered AN concomitantly with specific psychopathological traits support the hypothesis of an organic dysfunction of this area and corroborates with previous literature reports of AN cases induced by temporal lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639866     DOI: 10.1016/j.biopsych.2008.06.006

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  18 in total

Review 1.  Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Authors:  Timothy D Brewerton
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Psychopathology in underweight and weight-recovered females with anorexia nervosa.

Authors:  N Schneider; H Salbach-Andrae; J V Merle; J Hein; E Pfeiffer; U Lehmkuhl; S Ehrlich
Journal:  Eat Weight Disord       Date:  2009-12       Impact factor: 4.652

3.  5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

Authors:  Ursula F Bailer; Cinnamon S Bloss; Guido K Frank; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Mark A Geyer; Angela Wagner; Carl R Becker; Nicholas J Schork; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2010-09-24       Impact factor: 4.861

Review 4.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

5.  Advances in the diagnosis of anorexia nervosa and bulimia nervosa using brain imaging.

Authors:  Guido K W Frank
Journal:  Expert Opin Med Diagn       Date:  2012-05-01

Review 6.  Animal models of eating disorders.

Authors:  S F Kim
Journal:  Neuroscience       Date:  2012-03-21       Impact factor: 3.590

Review 7.  Serotonin: imaging findings in eating disorders.

Authors:  Ursula F Bailer; Walter H Kaye
Journal:  Curr Top Behav Neurosci       Date:  2011

Review 8.  Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa.

Authors:  Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Amanda Bischoff-Grethe
Journal:  Trends Neurosci       Date:  2013-01-18       Impact factor: 13.837

9.  Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa.

Authors:  Yunjung Kim; Sara E Trace; James J Crowley; Kimberly A Brownley; Robert M Hamer; David S Pisetsky; Patrick F Sullivan; Cynthia M Bulik
Journal:  Psychiatry Res       Date:  2013-06-15       Impact factor: 3.222

10.  Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series.

Authors:  Kyoji Okita; Akihiro Shiina; Michiko Nakazato; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2013-03-09       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.